Page last updated: 2024-08-23

raloxifene hydrochloride and centchroman

raloxifene hydrochloride has been researched along with centchroman in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fournier, B; Hall, TJ; Nyugen, H; Schaueblin, M1
Narayana Murthy, PS; Sengupta, S; Sharma, S; Singh, MM1

Other Studies

2 other study(ies) available for raloxifene hydrochloride and centchroman

ArticleYear
The bone-specific estrogen centchroman inhibits osteoclastic bone resorption in vitro.
    Biochemical and biophysical research communications, 1995, Nov-13, Volume: 216, Issue:2

    Topics: Animals; Animals, Newborn; Bone Resorption; Calcitonin; Cells, Cultured; Centchroman; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Humans; Kinetics; Molecular Structure; Osteoclasts; Piperidines; Raloxifene Hydrochloride; Rats; Structure-Activity Relationship

1995
Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    The Journal of steroid biochemistry and molecular biology, 2006, Volume: 100, Issue:4-5

    Topics: Animals; Apoptosis; Benzopyrans; Bone Density; Bone Marrow Cells; Bone Resorption; Calcium; Cell Differentiation; Cells, Cultured; Female; Lumbar Vertebrae; Mice; Mice, Inbred BALB C; Organ Size; Osteoclasts; Ovariectomy; Phosphorus; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Stem Cells; Transforming Growth Factor beta; Transforming Growth Factor beta3; Uterus

2006